骨髓增生异常综合征 - Suppr

Myelodysplastic syndrome.

作者信息

Nakao Shinji, Deeg H Joachim, Ishikawa Takayuki, Marsh Judith, List Alan, Tomonaga Masao

机构信息

Cellular Transplantation Biology, Division of Cancer Medicine, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa City, Ishikawa 920-8641, Japan.

出版信息

Int J Hematol. 2005 Dec;82(5):412-6. doi: 10.1532/IJH97.05139.

DOI:10.1532/IJH97.05139

PMID:16533744

Abstract

摘要

相似文献

Myelodysplastic syndrome.

Int J Hematol. 2005 Dec;82(5):412-6. doi: 10.1532/IJH97.05139.

The role of the immune system in myelodysplasia: implications for therapy.

Semin Hematol. 2008 Jan;45(1):39-48. doi: 10.1053/j.seminhematol.2007.11.006.

[Myelodysplastic syndrome].

Gan To Kagaku Ryoho. 2005 Mar;32(3):287-91.

[Myelodysplastic syndromes: treatment strategy up-to-date].

Rinsho Ketsueki. 2014 Jan;55(1):12-21.

Immunosuppressive therapy for myelodysplastic syndromes: refining the indications.

Curr Hematol Malig Rep. 2008 Jan;3(1):23-8. doi: 10.1007/s11899-008-0005-y.

Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.

Med Pediatr Oncol. 2003 May;40(5):334-5. doi: 10.1002/mpo.10228.

Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.

Cancer. 1997 Apr 15;79(8):1548-51. doi: 10.1002/(sici)1097-0142(19970415)79:8<1548::aid-cncr16>3.0.co;2-y.

Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.

Haematologica. 2007 Mar;92(3):397-400. doi: 10.3324/haematol.10683.

Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.

Hematol Oncol Clin North Am. 2010 Apr;24(2):331-41. doi: 10.1016/j.hoc.2010.02.009.

[Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].

Rinsho Ketsueki. 2002 Oct;43(10):911-7.

引用本文的文献

[The value of WT1 mRNA expression level in the diagnosis and prognosis evaluation of myelodysplastic syndromes].

Zhonghua Xue Ye Xue Za Zhi. 2024 Oct 14;45(10):909-915. doi: 10.3760/cma.j.cn121090-20240507-00174.

本文引用的文献

Efficacy of lenalidomide in myelodysplastic syndromes.

N Engl J Med. 2005 Feb 10;352(6):549-57. doi: 10.1056/NEJMoa041668.

DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Int J Hematol. 2004 Aug;80(2):128-35. doi: 10.1532/ijh97.04094.

Novel therapies for myelodysplastic syndromes.

Cancer. 2004 Jul 15;101(2):226-41. doi: 10.1002/cncr.20381.

Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.

Blood. 2004 Oct 15;104(8):2425-31. doi: 10.1182/blood-2004-05-1839. Epub 2004 Jun 24.

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

Leuk Res. 2004 Aug;28(8):791-803. doi: 10.1016/j.leukres.2003.11.018.

The role of angiogenesis in the biology and therapy of myelodysplastic syndromes.

Curr Hematol Rep. 2004 May;3(3):184-91.

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.

Blood. 2003 Oct 15;102(8):3025-7. doi: 10.1182/blood-2002-11-3325. Epub 2003 Jun 26.

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.

Lancet. 2003 May 10;361(9369):1597-602. doi: 10.1016/S0140-6736(03)13309-0.

Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.

Blood. 2003 Aug 15;102(4):1211-6. doi: 10.1182/blood-2002-12-3706. Epub 2003 Apr 3.

Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Leuk Lymphoma. 2002 Nov;43(11):2083-92. doi: 10.1080/1042819021000016186.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Myelodysplastic syndrome.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献